Overview:
VoxNeuro Inc. introduces VoxNeuro CORE, an advanced cognitive health assessment system utilizing neurophysiological data from EEG-based brain performance software. This innovative approach aims to revolutionize cognitive health assessments by providing objective measures of cognitive function across various clinical conditions.
Key Features:
- VoxNeuro CORE combines established neuropsychological tests with EEG-based cognitive biomarkers to deliver comprehensive cognitive performance scores.
- The system offers rapid and non-invasive assessment processes, making it accessible and suitable for a wide range of patients aged 12-90.
- Cloud-based software generates instant patient reports, enabling healthcare professionals to track cognitive changes over time efficiently.
Industry-Leading Research:
- VoxNeuro’s research is backed by a team of industry leaders and supported by thousands of articles validating EEG-based cognitive biomarkers.
- The normative database used by VoxNeuro CORE is validated across age and sex cohorts from 12-90, ensuring accuracy and reliability.
Addressing Brain Health Crisis:
- With the increasing prevalence of traumatic brain injuries (TBIs) and cognitive impairments, VoxNeuro aims to address the unfolding brain health crisis.
- The system provides valuable insights into cognitive function, helping healthcare professionals manage brain health and wellness effectively.
Overcoming Limitations of Traditional Assessments:
- While traditional cognitive assessments like the Montreal Cognitive Assessment (MoCA) and full neuropsychological batteries have their merits, VoxNeuro CORE offers a more objective and comprehensive approach.
- By leveraging neurophysiological data, VoxNeuro CORE overcomes the limitations of traditional assessments, providing valuable adjunctive tools for evaluating cognitive function.
Regulatory Compliance and Intended Use:
- VoxNeuro is registered with the FDA and Health Canada, ensuring compliance with regulatory standards.
- The system is intended for use as an adjunctive tool for evaluating cognitive function in individuals aged 12-90 and should be interpreted by qualified healthcare professionals.
VoxNeuro Inc.’s VoxNeuro CORE represents a significant advancement in cognitive health assessment technology. By leveraging EEG-based cognitive biomarkers and established neuropsychological tests, VoxNeuro CORE offers a comprehensive and objective solution for evaluating cognitive function across various clinical conditions. With its industry-leading research and commitment to addressing the brain health crisis, VoxNeuro is poised to make a meaningful impact in the field of cognitive health assessment.